Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erqi L Pollom

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Neuro-Oncology Advances|June 22, 2026
A WEb-Accessible comprehensiVE platform for automatic vestibular schwannoma segmentation and longitudinal volumetric trackingRiya Prashad, Gregory Szalkowski, Jen-Yeu Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2025
Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysisDaniella Klebaner, Eleanor Brown, George A Fisher, et al.
Neurosurgery Practice|October 30, 2025
Efficacy and Safety of CyberKnife Stereotactic Radiosurgery for Occipital Condyle MetastasisDavid J Park, Harini Voruganti, Shreyas Annagiri, et al.
Neuro-Oncology|February 1, 2020
A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomesMelissa Azoulay, Steven D Chang, Iris C Gibbs, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life ResultsErqi L Pollom, Dylann Fujimoto, Jacob Wynne, et al.
Practical Radiation Oncology|February 3, 2023
Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant TemozolomideMaria G Mendoza, Melissa Azoulay, Steven D Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2019
Nodular Leptomeningeal Disease-A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver ReliabilityBrandon E Turner, Roshan S Prabhu, Stuart H Burri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2026
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational CohortAndrew M Moon, Ted K Yanagihara, Laura A Dawson, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Neuro-Oncology Advances|June 22, 2026
A WEb-Accessible comprehensiVE platform for automatic vestibular schwannoma segmentation and longitudinal volumetric trackingRiya Prashad, Gregory Szalkowski, Jen-Yeu Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2025
Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysisDaniella Klebaner, Eleanor Brown, George A Fisher, et al.
Neurosurgery Practice|October 30, 2025
Efficacy and Safety of CyberKnife Stereotactic Radiosurgery for Occipital Condyle MetastasisDavid J Park, Harini Voruganti, Shreyas Annagiri, et al.
Neuro-Oncology|February 1, 2020
A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomesMelissa Azoulay, Steven D Chang, Iris C Gibbs, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life ResultsErqi L Pollom, Dylann Fujimoto, Jacob Wynne, et al.
Practical Radiation Oncology|February 3, 2023
Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant TemozolomideMaria G Mendoza, Melissa Azoulay, Steven D Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2019
Nodular Leptomeningeal Disease-A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver ReliabilityBrandon E Turner, Roshan S Prabhu, Stuart H Burri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2026
Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational CohortAndrew M Moon, Ted K Yanagihara, Laura A Dawson, et al.
Pageof 13